Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752Archive for June, 2021
Today, the U.S. Food and Drug Administration is providing an update on its ongoing sampling and testing efforts designed to better understand the occurrence of…
Today, the U.S. Food and Drug Administration approved Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component of a chemotherapy regimen to treat acute lymphoblastic leukemia…
The following quote is attributed to Suzanne Schwartz, M.D., M.B.A., director of the Office of Strategic Partnerships and Technology Innovation in the FDA’s Center for…
The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: The FDA has sent to Congress…
The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: Today, the FDA is announcing revisions…
The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic…
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) for the treatment of hospitalized adults and…
The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: FDA issued a Drug Safety Communication…
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with…
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. The…
Latest Posts
